Skip to main content

Table 2 Prevalence of Select Non-Communicable Diseases (NCDs) by age-group (JHLS-II data, 2007/2008; N = 2551)

From: Social determinants of multimorbidity in Jamaica: application of latent class analysis in a cross-sectional study

 

Age grouping (%)

15–24

(n = 464)

25–34 (n = 519)

35–44 (n = 531)

45–54 (n = 475)

55–64 (n = 296)

65–74 (n = 266)

All ages (N = 2551)

NCD Prevalence

 Hypertension***

6.43

11.38

22.97

47.31

59.66

67.03

25.33

 Obesity***

12.39

24.12

32.55

34.74

30.11

27.66

25.23

 Hypercholesterolemia***

3.85

7.25

12.18

19.50

22.18

24.21

11.53

 Diabetes mellitus***

1.12

2.32

6.89

14.28

18.02

30.37

7.86

 Asthma*

9.79

6.23

6.66

6.38

3.48

3.64

6.85

 Arthritis***

0.13

1.13

3.16

5.75

18.04

29.01

5.24

 Cardiovascular disease***

1.73

1.66

3.53

6.67

11.03

17.42

4.62

 Mental health disorders

2.95

3.01

3.31

2.84

3.52

1.25

2.96

 COPD

2.52

2.94

2.08

4.79

2.66

2.04

2.80

 Stroke***

0.18

0.41

0.47

2.08

3.27

6.16

1.21

 Glaucoma***

0.00

0.11

0.99

0.75

3.08

7.33

1.10

 Multimorbidity (2+ NCDs)***

7.44

10.50

24.16

42.13

51.12

64.01

24.05

 Multimorbidity (3+ NCDs)***

0.89

4.13

8.06

19.67

25.29

35.56

10.16

 Mean number of NCDs reported (95% CI)***

0.41 (0.34, 0.48)

0.61 (0.52, 0.70)

0.95 (0.85, 1.04)

1.45 (1.30, 1.60)

1.75 (1.58, 1.92)

2.16 (1.98, 2.34)

0.95 (0.90, 0.99)

  1. COPD = chronic obstructive pulmonary disease
  2. Note: Values are weighted proportions (%) or mean (95% CI)
  3. p-value for difference across age-groups based on chi-squared (χ2) test or one-way analysis of variance (ANOVA), as appropriate (*p < 0.05; **p < 0.01; ***p < 0.001)